Skip to main content
. 2017 May 19;9(2):17. doi: 10.3390/pharmaceutics9020017

Figure 5.

Figure 5

In vitro drug release profile of a commercially available 5 mg prednisolone tablet compared to prednisolone release from the kafirin microparticles containing an equivalent of 5 mg prednisolone. Prednisolone release was measured in conditions simulating the stomach for 1 h, followed by the small intestine for 6 h, (a) without enzymes, and (b) in presence of the enzymes pepsin and pancreatin, respectively. Values are mean ± SEM (n = 3).